Year: 2022
Reference No.: IB No. 2022-053
Category: Summary of Awarded Contract
Approved Budget for the Contract: 700,000,000.00
Awardee/Supplier: Zuellig Pharma Corporation – Interphil Laboratories, Inc., Joint Venture
Date of NOA: Thursday, August 18, 2022
PO/Contract No.: GOP-C-2022-080
Effectivity and Expiration Date of Contract: Wednesday, September 21, 2022 to Saturday, February 18, 2023
NTP Contract Date: Friday, September 16, 2022
Contract Period: 1st Tranche = 1,000,000 doses for 60 cd upon receipt of approved NTP and 2nd Tranche = 1,000,000 doses for 150 cd upon receipt of approved NTP
Name of Winning Bidder: Zuellig Pharma Corporation – Interphil Laboratories, Inc., Joint Venture
Official Business Address: KM.14 West Service Rd. SSH cor. Edison Ave., Brgy. Sun Valley, Paranaque City
Amount of Contract Awarded: 631,360,000.00
Date of Award: Thursday, August 18, 2022
Date of Acceptance: Friday, August 19, 2022
Implementing Office/End-User Unit/s: Disease Prevention and Control Bureau
Date Posted: January 25, 2023